<p>This study developed a bio-based gel using bacterial cellulose nanofibrils (BCNF) as a natural moisturizing and delivery matrix, and xanthone, an active ingredient from <i>Garcinia mangostana</i> peel, with known antimicrobial, anti-inflammatory, and antioxidant properties. BCNF was produced through a mechanical defibrillation process, resulting in nanofibers with an average diameter of 32.12 ± 2.54&#xa0;nm. FTIR and WAXS analyses confirmed successful Xanthone incorporation into the BCNF matrix. The composite demonstrated moderate anti-inflammatory activity, inhibiting albumin denaturation with an IC50 value of 33.00 ± 2.72&#xa0;mg/mL and nitric oxide inhibition of 28.66 ± 3.75% similar to triamcinolone acetonide, at the concentration of 1&#xa0;mg/mL. Antibacterial assays revealed effective inhibition of <i>Cutibacterium acnes</i> and <i>Staphylococcus aureus</i>, with MIC values of 0.976 and 3.906&#xa0;mg/mL, respectively. The acne gel formulated with BCNF/Xanthone showed stable antioxidant activity over 30 days, as evaluated by DPPH assay. Overall, the formulation 4 (F4), which used BCNF/Xanthone as the sole stabilizer and bioactive carrier showed the highest free radical scavenging activity and killing efficiency against <i>S. aureus</i>. Rheological assessments confirmed that BCNF/Xanthone enhanced gel viscosity and resulted in non-Newtonian, shear-thinning flow behavior, and stable pH value after 30 days, suitable for topical application. These findings suggest that BCNF/Xanthone offer a sustainable, effective alternative with multifunctional benefits for acne management.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Formulation of bacterial cellulose nanofibrils incorporated with xanthone as functional green ingredients for cosmeceutical products

  • Sanattapon Kongtaveesombat,
  • Selorm Torgbo,
  • Nuntaporn Kamonsutthipaijit,
  • Bandhita Wanikorn,
  • Prakit Sukyai

摘要

This study developed a bio-based gel using bacterial cellulose nanofibrils (BCNF) as a natural moisturizing and delivery matrix, and xanthone, an active ingredient from Garcinia mangostana peel, with known antimicrobial, anti-inflammatory, and antioxidant properties. BCNF was produced through a mechanical defibrillation process, resulting in nanofibers with an average diameter of 32.12 ± 2.54 nm. FTIR and WAXS analyses confirmed successful Xanthone incorporation into the BCNF matrix. The composite demonstrated moderate anti-inflammatory activity, inhibiting albumin denaturation with an IC50 value of 33.00 ± 2.72 mg/mL and nitric oxide inhibition of 28.66 ± 3.75% similar to triamcinolone acetonide, at the concentration of 1 mg/mL. Antibacterial assays revealed effective inhibition of Cutibacterium acnes and Staphylococcus aureus, with MIC values of 0.976 and 3.906 mg/mL, respectively. The acne gel formulated with BCNF/Xanthone showed stable antioxidant activity over 30 days, as evaluated by DPPH assay. Overall, the formulation 4 (F4), which used BCNF/Xanthone as the sole stabilizer and bioactive carrier showed the highest free radical scavenging activity and killing efficiency against S. aureus. Rheological assessments confirmed that BCNF/Xanthone enhanced gel viscosity and resulted in non-Newtonian, shear-thinning flow behavior, and stable pH value after 30 days, suitable for topical application. These findings suggest that BCNF/Xanthone offer a sustainable, effective alternative with multifunctional benefits for acne management.